Frequently asked
What you actually want to know.
Detailed answers about the therapies we use. Same information we share in evaluation, public so you arrive informed.
The four therapies
Therapy 01
Mesenchymal stem cells
- What are they?
- Adult human allogeneic mesenchymal stem cells (HPEpC), expanded in laboratory. They are pluripotent — capable of differentiating into osteoblasts, chondrocytes and adipocytes — and immunomodulatory, meaning they regulate the body's inflammatory response.
- What are they used for?
- Chronic-degenerative, autoimmune and neurodegenerative conditions. They migrate to areas of inflammation or tissue damage and promote local regeneration.
- How are they administered?
- Intravenously, perilesionally, intra-articularly or subdermally, depending on indication, in doses calibrated to each candidate.
- Are they safe?
- Allogeneic protocols have an extensive safety record when sourced from regulated laboratories with full traceability. Risks are explained in informed consent before any procedure.
Therapy 02
Allogeneic fibroblasts
- What are they?
- Cells isolated from healthy young donors and aseptically expanded. They are the primary source of type I and III collagen, fibronectin, glycosaminoglycans, pro-elastin and growth factors.
- What do they do?
- They reorganize the extracellular matrix and restore mechanical integrity to the dermis. The result is structural — not a quick aesthetic fix.
- Indication
- Nasolabial folds, scarring, prevention of structural aging. Always evaluated against your skin biology and history.
- How are they given?
- Intradermal injection in supervised sessions, with markers CD29 · CD73 · CD90 · CD105 for traceability.
- What are they?
- Nano vesicles (30–150 nm) secreted by stem cells. Not cells, not medication — biological messengers.
- What do they carry?
- Signaling proteins, RNA and bioactive factors. They teach receiving cells when and how to function.
- Why are they unique?
- They cross the blood-brain barrier and circulate systemically without the risk of cellular embolism. This makes them suitable for indications where cellular protocols are contraindicated.
- How are they handled?
- Conservation at 2–8 °C, protected from light. Administered in clinical settings under medical supervision.
Therapy 04
Platelet-Rich Plasma (PRP)
- What is it?
- Plasma rich in platelets, drawn from your own blood and concentrated through centrifugation. Autologous — meaning it comes from you and returns to you the same day.
- What is it used for?
- Joint, tendon and ligament recovery; skin and scalp regeneration; post-surgical and post-injury healing.
- Why is it useful?
- Platelets release growth factors that accelerate natural tissue repair. Because it's your own blood, the immunological risk profile is minimal.
- Is it a stand-alone therapy?
- It can be, or it can complement other regenerative protocols. The clinical team decides based on your case.
General questions
- Who can apply?
- Adults seeking medical evaluation for regenerative protocols. Candidacy is confirmed only after clinical review.
- How long does the process take?
- From application to verdict, 2–3 days. From candidacy confirmation to protocol, the timeline is individual and follows biological criteria, not calendar pressure.
- What if I'm not a candidate?
- You receive an honest answer and, when relevant, recommendations for preparation. Non-candidacy is also a clarity gain.
- Are results guaranteed?
- No. Regenerative medicine works with biology and conditions, not with promises. We share realistic expectations during evaluation.
- Is everything documented?
- Yes. Every protocol is traceable, supervised, and stays in your clinical file with regulatory traceability.
Regénesis House does not replace medical care, does not promise cures, does not guarantee results, and should not be interpreted as universal treatment. Any regenerative protocol proceeds only after professional evaluation, informed consent, and individual candidacy review. The provocation lies in listening to the body before it is too late.
